InhaleRx Limited (ASX: IRX) is a clinical stage drug development company focused on developing precision inhaled therapeutics to address unmet medical needs in pain management and mental health treatment.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 2 Queen St, Suite 103,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://inhalerx.com.au
- Keywords
- cannabinoids.
- HQ
- Melbourne, Victoria
Inhalerx Ltd (Asx: Irx) Questions
Inhalerx Ltd (Asx: Irx)'s website is http://inhalerx.com.au
Inhalerx Ltd (Asx: Irx)'s LinkedIn profile is https://au.linkedin.com/company/inhalerx
Inhalerx Ltd (Asx: Irx) has
6 employees.
View email and phone details for 6
employees at Inhalerx Ltd (Asx: Irx).
Inhalerx Ltd (Asx: Irx)'s industry is
Biotechnology Research
Inhalerx Ltd (Asx: Irx)'s top competitors are
Ingenū Cro,
Green Zebras S.a.,
Cannvalate,
Spring Sciences Australia,
Ananda Scientific,
Mycb1 Group B.v.,
Adrexpharma Gmbh,
Verve Dynamics (Pty) Ltd,
Flowzz.com,
Pharmaweed Pro.
Inhalerx Ltd (Asx: Irx)'s categories are Biotechnology Research
Inhalerx Ltd (Asx: Irx)'s founding year is 2016
